Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
Fexlamose is being developed as a chronic treatment for COPD and asthma in conjunction with standard therapies, to improve ...
Young teens might think smoking makes them look cool, but it’s likely to take their breath away in adulthood, a new st ...
A study reveals childhood smoking significantly increases COPD risk in adulthood, highlighting the need for targeted ...
Childhood smoking before age 15 increases a person's risk of developing chronic obstructive pulmonary disease (COPD), ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is needed to improve holistic patient care, according to a new editorial.
For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.
Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...
The Ministry of Public Health (MoPH) is intensifying efforts to raise awareness about asthma and chronic obstructive ...
The Ministry of Public Health (MoPH) is intensifying efforts to raise awareness about asthma and chronic obstructive ...